Estee Lauder Companies (The) (EL) Earnings Date & Reports

Key Takeaways

• Estée Lauder reported adjusted diluted earnings per share (EPS, or profit per share) of $0.72, up 125% from $0.32 a year earlier and well above the roughly $0.51 consensus estimate.
• Net sales rose about 7% year over year to $3.72 billion, with organic net sales (growth excluding currency swings and acquisitions) up 6%.
• Fragrance was the standout, with organic sales up 20%, while Skin Care rose 4%, Makeup grew 1%, and Hair Care was roughly flat.
• Gross margin expanded 240 basis points (2.4 percentage points) to 75.7%, and adjusted operating margin widened 480 basis points to 12.1%.
• Management raised its full-year fiscal 2027 outlook for organic sales growth, operating margin, and adjusted EPS.
• For more context on this ticker's Major News, Today's Price Move, Price Targets, and Forecast, explore these dedicated pages for additional detail.
• Discover Trending AI Robots to see AI-driven trading strategies currently gaining traction in the market.

Earnings Context and Why It Matters

Estée Lauder's fiscal 2027 first quarter is a key checkpoint for the company's "Beauty Reimagined" turnaround strategy. After a prolonged stretch of weak sales and margin pressure, the beauty giant has now posted five consecutive quarters of organic sales growth and margin expansion, and the latest results signal the recovery may be broadening beyond its strongest brands. Investors are watching closely because the quarter's mix of accelerating fragrance demand, progress in mainland China, and disciplined cost management tests whether management can convert one-off tailwinds into durable, diversified growth.

Reported Results

For the fiscal first quarter ended September 30, 2026, Estée Lauder reported net sales of $3.72 billion, up about 7% year over year, with organic net sales growth of 6%. Adjusted diluted EPS came in at $0.72, a 125% increase from $0.32 in the prior-year period and above consensus estimates of approximately $0.51.

Profitability improved markedly. Gross margin expanded 240 basis points to 75.7%, while adjusted operating margin widened 480 basis points to 12.1%. Management attributed the gains to sales leverage, strategic pricing, procurement savings, and manufacturing efficiencies. Fragrance led category growth with a 20% organic increase, driven by Le Labo, TOM FORD, Jo Malone London, and KILIAN PARIS. Skin Care rose 4%, Makeup grew 1% (its second consecutive quarter of organic growth), and Hair Care was flat.

Geographically, growth was broad-based, with mainland China up 9% organically and priority emerging markets up 15%. The company also raised its full-year fiscal 2027 guidance, now projecting organic net sales growth of 4.0% to 5.5% (up from 3% to 5%) and adjusted diluted EPS of $3.20 to $3.45 (up from $3.10 to $3.35).

AI Screener

Tickeron's AI Screener is an AI-powered stock and exchange-traded fund (ETF) discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to see how it can support your research process.

Market Reaction and Investor Sentiment

Shares of Estée Lauder moved higher in premarket trading following the release, as investors responded to the earnings beat and the raised full-year outlook. The market's favorable reaction reflected both the size of the EPS outperformance and management's confidence in sustained momentum. Sentiment was tempered somewhat by the fact that the full-year organic sales guidance, at 4.0% to 5.5%, still sits below the 6% growth delivered in the first quarter, with management signaling that growth is expected to be stronger in the first half of the fiscal year due to the timing of product launches and easier comparisons.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors will focus on whether Estée Lauder can sustain its recovery as favorable comparisons fade. Management has been explicit that the first half of fiscal 2027 should grow faster than the second half, given the phasing of innovation and a higher base in travel retail later in the year.

One key area to watch is the durability of the fragrance boom. The company's 20% organic growth in the category was powered by luxury brands and new launches, and the rollout of the Estée Lauder Glimmer fragrance into additional markets is a potential catalyst. In parallel, investors will monitor whether Skin Care momentum broadens beyond La Mer and The Ordinary.

Cost discipline and margin execution also remain central. The company's Profit Recovery and Growth Plan (PRGP, its restructuring and savings program) is expected to deliver the vast majority of its run-rate benefits by the end of fiscal 2027, while the newer "One ELC" operating model is intended to generate ongoing efficiency. Commodity and freight inflation could pressure margins in the back half of the year.

Finally, geographic dynamics matter. Mainland China has delivered seven consecutive quarters of market share gains, and the recent completion of the Forest Essentials acquisition strengthens the company's position in India's fast-growing prestige beauty market. Geopolitical risks, including the Middle East conflict and potential tariff impacts, remain watchpoints that management has flagged in its outlook assumptions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations